Transplantation Proceedings
Volume 35, Issue 3, Supplement , Pages S67-S72 , May 2003

Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus

  • J.R Chapman

      Affiliations

    • Westmead Hospital and University of Sydney; Sydney, Australia
    • Corresponding Author InformationAddress reprint requests to Dr Jeremy R. Chapman, Director of Renal Medicine, Westmead Hospital and University of Sydney, Westmead, Sydney NSW 2145, Australia.

References 

  1. In:  Russ G editors. ANZDATA Registry Report. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry; 2000;
  2. The Tricontinental Mycophenalate Mofetil Renal Transplant Study Group . Transplantation. 1996;61:1029
  3. Chapman JR, Griffiths D, Harding N, et al.  Lancet. 1985;1:128
  4. Calne RY, Rolles K, White DJ, et al.  Lancet. 1979;2:1033
  5. Kasiske BL, Heim-Duthoy K, Ma JZ. JAMA. 1993;269:395
  6. Kasiske BL, Chakkera HA, Louis TA, et al.  J Am Soc Nephrol. 2000;11:1910
  7. Rapamune US Study Group Kahan BD. Lancet. 2000;356:194
  8. Rapamune Global Study Group MacDonald AS. Transplantation. 2001;71:271
  9. Groth CG, Backman L, Morales JM, et al.  Transplantation. 1999;67:1036
  10. Reitamo S, Spuls P, Sassolas B, et al.  Br J Dermatol. 2001;145:438
  11. Gonwa TA, Hricik DE, Brinker K, et al: Transplantation 74:1560, 2002
  12. Johnson RW, Kreis H, Oberbauer R, et al.  Transplantation. 2001;72:777
  13. Oberbauer R, Kreis H, Johnson RWG, et al: Transplantation 2003 in press
  14. Nankivell BJ, Chapman JR. Transplantation. 1995;59:1683
  15. Opelz G. Transplant Proc. 2000;32:647
  16. Kuypers D, Chapman JR, O’Connell PJ, et al.  Transplantation. 1999;67:1

PII: S0041-1345(03)00236-7

doi: 10.1016/S0041-1345(03)00236-7

Transplantation Proceedings
Volume 35, Issue 3, Supplement , Pages S67-S72 , May 2003

Article Tools

* Image Usage & Resolution